
David Topper
North America, New York, United States, New York
Description
David Topper is the current Chief Financial Officer of Inmagene Biopharmaceuticals. He previously worked at General Atlantic as a Partner. D...
Investor Profile
David Topper has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Analytics, Financial Services, FinTech.
Stage Focus
- Seed (100%)
Country Focus
- United States (100%)
Industry Focus
- Analytics
- Financial Services
- Fintech
- Venture Capital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.